Wen-Hui Bai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Wen-Hui Bai has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Chen-Liang Zhou
Department of Critical Care Medicine, Eastern Campus, Renmin Hospital of Wuhan University, Wuhan 430200, China
3 shared publications - Li Cheng
Department of Critical Care Medicine, Eastern Campus, Renmin Hospital of Wuhan University, Wuhan 430200, China
3 shared publications - Jing-Jing Yang
Department of Critical Care Medicine, Eastern Campus, Renmin Hospital of Wuhan University, Wuhan, Hubei, 430200, China
2 shared publications - Wanshan Ning
Affiliation Institute for Clinical Medical Research, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, Fujian, China
2 shared publications - Long Zhou
Department of Neurosurgery, Eastern Campus, Renmin Hospital of Wuhan University, Wuhan 430200, China
1 shared publication - Lun Gao
Department of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan 430060, China
1 shared publication
Latest Publications
- Open Access
Development and validation of a nomogram for predicting in-hospital survival rates of patients with COVID-19
- Open Access
- 29 June 2023
- Published by MDPI AG in Diagnostics
- Vol. 13 (13) , 2207
Development and Validation of a Nomograph Model for Post-Operative Central Nervous System Infection after Craniocerebral Surgery
Purpose: A nomograph model of predicting the risk of post-operative central nervous system infection (PCNSI) after craniocerebral surgery was established and validated. Methods: The clinical medical records of patients after cranial surgery in Renmin Hospital of Wuhan University from January 2020 to September 2022 were collected, of whom 998 patients admitted to Shouyi Hospital District were used as the training set and 866 patients admitted to Guanggu Hospital District were used as the validation set. Lasso regression was applied to screen the independent variables in the training set, and the model was externally validated in the validation set. Results: A total of 1864 patients after craniocerebral surgery were included in this study, of whom 219 (11.75%) had PCNSI. Multivariate logistic regression analysis showed that age > 70 years, a previous history of diabetes, emergency operation, an operation time ≥ 4 h, insertion of a lumbar cistern drainage tube ≥ 72 h, insertion of an intracranial drainage tube ≥ 72 h, intraoperative blood loss ≥ 400 mL, complicated with shock, postoperative albumin ≤ 30 g/L, and an ICU length of stay ≥ 3 days were independent risk factors for PCNSI. The area under the curve (AUC) of the training set was 0.816 (95% confidence interval (95%CI), 0.773–0.859, and the AUC of the validation set was 0.760 (95%CI, 0.715–0.805). The calibration curves of the training set and the validation set showed p-values of 0.439 and 0.561, respectively, with the Hosmer–Lemeshow test. The analysis of the clinical decision curve showed that the nomograph model had high clinical application value. Conclusion: The nomograph model constructed in this study to predict the risk of PCNSI after craniocerebral surgery has a good predictive ability.
- 29 June 2023
- Published by MDPI AG in Diagnostics
- Vol. 13 (13) , 2207
Open AccessDevelopment and Validation of a Nomograph Model for Post-Operative Central Nervous System Infection after Craniocerebral Surgery
Purpose: A nomograph model of predicting the risk of post-operative central nervous system infection (PCNSI) after craniocerebral surgery was established and validated. Methods: The clinical medical records of patients after cranial surgery in Renmin Hospital of Wuhan University from January 2020 to September 2022 were collected, of whom 998 patients admitted to Shouyi Hospital District were used as the training set and 866 patients admitted to Guanggu Hospital District were used as the validation set. Lasso regression was applied to screen the independent variables in the training set, and the model was externally validated in the validation set. Results: A total of 1864 patients after craniocerebral surgery were included in this study, of whom 219 (11.75%) had PCNSI. Multivariate logistic regression analysis showed that age > 70 years, a previous history of diabetes, emergency operation, an operation time ≥ 4 h, insertion of a lumbar cistern drainage tube ≥ 72 h, insertion of an intracranial drainage tube ≥ 72 h, intraoperative blood loss ≥ 400 mL, complicated with shock, postoperative albumin ≤ 30 g/L, and an ICU length of stay ≥ 3 days were independent risk factors for PCNSI. The area under the curve (AUC) of the training set was 0.816 (95% confidence interval (95%CI), 0.773–0.859, and the AUC of the validation set was 0.760 (95%CI, 0.715–0.805). The calibration curves of the training set and the validation set showed p-values of 0.439 and 0.561, respectively, with the Hosmer–Lemeshow test. The analysis of the clinical decision curve showed that the nomograph model had high clinical application value. Conclusion: The nomograph model constructed in this study to predict the risk of PCNSI after craniocerebral surgery has a good predictive ability.
- Open Access
- 21 October 2022
- Published by MDPI AG in Diagnostics
- Vol. 12 (10) , 2562
Construction and Validation of Mortality Risk Nomograph Model for Severe/Critical Patients with COVID-19
Objective: A nomograph model of mortality risk for patients with coronavirus disease 2019 (COVID-19) was established and validated. Methods: We collected the clinical medical records of patients with severe/critical COVID-19 admitted to the eastern campus of Renmin Hospital of Wuhan University from January 2020 to May 2020 and to the north campus of Shanghai Ninth People’s Hospital, Shanghai JiaoTong University School of Medicine, from April 2022 to June 2022. We assigned 254 patients to the former group, which served as the training set, and 113 patients were assigned to the latter group, which served as the validation set. The least absolute shrinkage and selection operator (LASSO) and multivariable logistic regression were used to select the variables and build the mortality risk prediction model. Results: The nomogram model was constructed with four risk factors for patient mortality following severe/critical COVID-19 (≥3 basic diseases, APACHE II score, urea nitrogen (Urea), and lactic acid (Lac)) and two protective factors (percentage of lymphocyte (L%) and neutrophil-to-platelets ratio (NPR)). The area under the curve (AUC) of the training set was 0.880 (95% confidence interval (95%CI), 0.837~0.923) and the AUC of the validation set was 0.814 (95%CI, 0.705~0.923). The decision curve analysis (DCA) showed that the nomogram model had high clinical value. Conclusion: The nomogram model for predicting the death risk of patients with severe/critical COVID-19 showed good prediction performance, and may be helpful in making appropriate clinical decisions for high-risk patients.
- 21 October 2022
- Published by MDPI AG in Diagnostics
- Vol. 12 (10) , 2562
Open AccessConstruction and Validation of Mortality Risk Nomograph Model for Severe/Critical Patients with COVID-19
Objective: A nomograph model of mortality risk for patients with coronavirus disease 2019 (COVID-19) was established and validated. Methods: We collected the clinical medical records of patients with severe/critical COVID-19 admitted to the eastern campus of Renmin Hospital of Wuhan University from January 2020 to May 2020 and to the north campus of Shanghai Ninth People’s Hospital, Shanghai JiaoTong University School of Medicine, from April 2022 to June 2022. We assigned 254 patients to the former group, which served as the training set, and 113 patients were assigned to the latter group, which served as the validation set. The least absolute shrinkage and selection operator (LASSO) and multivariable logistic regression were used to select the variables and build the mortality risk prediction model. Results: The nomogram model was constructed with four risk factors for patient mortality following severe/critical COVID-19 (≥3 basic diseases, APACHE II score, urea nitrogen (Urea), and lactic acid (Lac)) and two protective factors (percentage of lymphocyte (L%) and neutrophil-to-platelets ratio (NPR)). The area under the curve (AUC) of the training set was 0.880 (95% confidence interval (95%CI), 0.837~0.923) and the AUC of the validation set was 0.814 (95%CI, 0.705~0.923). The decision curve analysis (DCA) showed that the nomogram model had high clinical value. Conclusion: The nomogram model for predicting the death risk of patients with severe/critical COVID-19 showed good prediction performance, and may be helpful in making appropriate clinical decisions for high-risk patients.